{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:49:35Z","timestamp":1787197775780,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NeoGenomics"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.anndiagpath.2020.151481","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T11:03:40Z","timestamp":1581764620000},"page":"151481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications"],"prefix":"10.1016","volume":"45","author":[{"given":"Stuart J.","family":"Schnitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edi","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil R.","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151481_bb0005","first-page":"419","article-title":"Lobular carcinoma in situ: a rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2020.151481_bb0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/his.12869","article-title":"E-cadherin immunohistochemistry in breast pathology: uses and pitfalls","volume":"68","author":"Canas-Marques","year":"2016","journal-title":"Histopathology."},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0020","series-title":"Breast Tumours","first-page":"71","article-title":"Lobular carcinoma in situ","author":"Chen","year":"2019"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151481_bb0025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2020.151481_bb0030","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","article-title":"Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","article-title":"Pleomorphic and florid lobular carcinoma in situ variants of the breast: a clinicopathologic study of 85 cases with and without invasive carcinoma from a single academic center","volume":"43","author":"Shamir","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151481_bb0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.arcmed.2010.08.010","article-title":"Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma","volume":"41","author":"Alvarado-Cabrero","year":"2010","journal-title":"Arch Med Res"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151481_bb0045","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.path.2017.09.009","article-title":"Lobular carcinoma in situ","volume":"11","author":"Wen","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-019-0449-8","article-title":"Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2\/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma","author":"Shamir","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0060","series-title":"Mod Pathol","article-title":"Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations","author":"Harrison","year":"2020"},{"issue":"7","key":"10.1016\/j.anndiagpath.2020.151481_bb0065","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1245\/s10434-011-1563-0","article-title":"The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?","volume":"18","author":"Bagaria","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2020.151481_bb0070","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.pas.0000213290.58283.82","article-title":"Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases","volume":"30","author":"Fadare","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0075","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","article-title":"Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature","volume":"45","author":"Foschini","year":"2019","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2017.12.011","article-title":"Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ","volume":"38","author":"Masannat","year":"2018","journal-title":"Breast."},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151481_bb0085","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0046-8177(92)90026-Y","article-title":"Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia","volume":"23","author":"Page","year":"1992","journal-title":"Hum Pathol"},{"issue":"2\u20133","key":"10.1016\/j.anndiagpath.2020.151481_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejcb.2004.12.016","article-title":"The p120 family of cell adhesion molecules","volume":"84","author":"Hatzfeld","year":"2005","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1083\/jcb.150.3.567","article-title":"Kreft B. p120 catenin regulates the actin cytoskeleton via Rho family GTPases","volume":"150","author":"Noren","year":"2000","journal-title":"J Cell Biol"},{"issue":"23","key":"10.1016\/j.anndiagpath.2020.151481_bb0100","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"19","key":"10.1016\/j.anndiagpath.2020.151481_bb0105","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/sj.onc.1207439","article-title":"Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions","volume":"23","author":"Sarrio","year":"2004","journal-title":"Oncogene."},{"issue":"8","key":"10.1016\/j.anndiagpath.2020.151481_bb0110","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1172\/JCI41695","article-title":"Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance","volume":"121","author":"Schackmann","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151481_bb0115","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0002-9440(10)63783-2","article-title":"Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer","volume":"164","author":"Shibata","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","article-title":"Invasive lobular carcinoma of the breast: morphology, biomarkers and \u2019omics","volume":"17","author":"McCart Reed","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151481_bb0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","article-title":"Aberrant expression of E-cadherin in lobular carcinomas of the breast","volume":"32","author":"Da Silva","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151481_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10689-016-9869-5","article-title":"CDH1 germline mutations and hereditary lobular breast cancer","volume":"15","author":"Corso","year":"2016","journal-title":"Fam Cancer"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151481_bb0135","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e3181f01916","article-title":"Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast","volume":"34","author":"Rakha","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151481_bb0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/ajcp\/105.4.394","article-title":"Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer","volume":"105","author":"Siitonen","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/FDHX-L92R-BATQ-2GE0","article-title":"Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications","volume":"115","author":"Acs","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1309\/JMRD-W08Y-6K8M-7AD8","article-title":"Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?","volume":"118","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/WMX7DRWTFVQP2LQT","article-title":"E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters","volume":"125","author":"Qureshi","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151481_bb0160","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.11197","article-title":"Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability","volume":"106","author":"Sarrio","year":"2003","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151481_bb0165","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/modpathol.2008.106","article-title":"Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma","volume":"21","author":"Choi","year":"2008","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/PAS.0000000000000159","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"38","author":"Wells","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0175","first-page":"209","article-title":"Lobular carcinoma in situ: current concepts and controversies","volume":"16","author":"Schnitt","year":"1999","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0180","series-title":"WHO classification of tumours of the breast","first-page":"78","article-title":"Lobular neoplasia","author":"Lakhani","year":"2012"},{"issue":"24","key":"10.1016\/j.anndiagpath.2020.151481_bb0185","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J Clin Oncol"},{"issue":"33","key":"10.1016\/j.anndiagpath.2020.151481_bb0190","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151481_bb0195","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1309\/B0DD-4M7H-GJG1-7KCW","article-title":"E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions","volume":"115","author":"Goldstein","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151481_bb0200","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.molonc.2014.12.005","article-title":"Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion","volume":"9","author":"Andrade","year":"2015","journal-title":"Mol Oncol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2020.151481_bb0205","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/cncr.20273","article-title":"Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma","volume":"100","author":"Hwang","year":"2004","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13058-016-0727-z","article-title":"Clonal relationships between lobular carcinoma in situ and other breast malignancies","volume":"18","author":"Begg","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151481_bb0215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","article-title":"Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: repertoire of somatic genetic alterations and clonal relationships","volume":"10","author":"Sakr","year":"2016","journal-title":"Mol Oncol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151481_bb0220","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrclinonc.2015.8","article-title":"Current management of lesions associated with an increased risk of breast cancer","volume":"12","author":"Morrow","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0225","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","article-title":"Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020)","volume":"23","author":"Nakhlis","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151481_bb0230","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cncr.27841","article-title":"Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision","volume":"119","author":"Murray","year":"2013","journal-title":"Cancer."},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0235","first-page":"211","article-title":"Recently recognized variants of lobular carcinoma in situ (LCIS) with an emphasis on management of LCIS on core needle biopsy","volume":"8","author":"Jacobs","year":"2003","journal-title":"Pathol Case Rev"},{"key":"10.1016\/j.anndiagpath.2020.151481_bb0240","series-title":"Current Concepts in Breast Pathology. Surgical Pathology Clinics. 2","first-page":"273","article-title":"Lobular carcinoma in situ, classical type and unusual variants","author":"Murray","year":"2009"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.semdp.2009.12.009","article-title":"Lobular breast carcinoma and its variants","volume":"27","author":"Rakha","year":"2010","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151481_bb0250","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.5858\/arpa.2014-0278-CC","article-title":"Lobular neoplasia: morphology and management","volume":"138","author":"Jorns","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151481_bb0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.breast.2013.01.003","article-title":"Challenges in the management of pleomorphic lobular carcinoma in situ of the breast","volume":"22","author":"Masannat","year":"2013","journal-title":"Breast."},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0260","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clbc.2011.08.007","article-title":"Pleomorphic lobular carcinoma in situ: treatment options for a new pathologic entity","volume":"12","author":"Murray","year":"2012","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"10.1016\/j.anndiagpath.2020.151481_bb0265","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/his.12353","article-title":"Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases","volume":"64","author":"Khoury","year":"2014","journal-title":"Histopathology."},{"issue":"13","key":"10.1016\/j.anndiagpath.2020.151481_bb0270","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151481_bb0275","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","article-title":"Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ","volume":"135","author":"Downs-Kelly","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151481_bb0280","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","article-title":"Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review","volume":"165","author":"De Brot","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1245\/s10434-018-6937-0","article-title":"Evaluating the rate of upgrade to invasive breast cancer and\/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ","volume":"26","author":"Nakhlis","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0290","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/tbj.12843","article-title":"Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast","volume":"24","author":"Fasola","year":"2018","journal-title":"Breast J"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151481_bb0295","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1245\/s10434-018-6591-6","article-title":"Treatment outcomes for pleomorphic lobular carcinoma in situ of the breast","volume":"25","author":"Desai","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151481_bb0300","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/tbj.12062","article-title":"Breast surgeon\u2019s survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ","volume":"19","author":"Blair","year":"2013","journal-title":"Breast J"},{"issue":"11","key":"10.1016\/j.anndiagpath.2020.151481_bb0305","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151481_bb0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","article-title":"Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases","volume":"16","author":"Susnik","year":"2016","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151481_bb0315","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2010.03634.x","article-title":"Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis","volume":"57","author":"Carder","year":"2010","journal-title":"Histopathology."},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151481_bb0320","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2214\/AJR.17.19088","article-title":"Pleomorphic lobular carcinoma in situ: imaging features, upgrade rate, and clinical outcomes","volume":"211","author":"Savage","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151481_bb0325","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2214\/ajr.176.5.1761255","article-title":"Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation","volume":"176","author":"Georgian-Smith","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151481_bb0330","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.breast.2007.04.005","article-title":"Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision","volume":"16","author":"Lavoue","year":"2007","journal-title":"Breast."},{"issue":"7","key":"10.1016\/j.anndiagpath.2020.151481_bb0335","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","article-title":"Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications","volume":"134","author":"Sullivan","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151481_bb0340","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2214\/AJR.11.8447","article-title":"Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?","volume":"199","author":"Niell","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2020.151481_bb0345","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00330-014-3132-y","article-title":"Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy","volume":"24","author":"Meroni","year":"2014","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151481_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2017.10.004","article-title":"Pleomorphic lobular carcinoma in situ diagnosed by breast Core biopsy: clinicopathologic features and correlation with subsequent excision","volume":"18","author":"Guo","year":"2018","journal-title":"Clin Breast Cancer"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:31:48Z","timestamp":1761078708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420300228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":70,"alternative-id":["S1092913420300228"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151481","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151481"}}